The Impact of Cannabis Use on Clinical Outcomes in Inflammatory Bowel Disease: A Population-based Longitudinal Cohort Study.
Danny GlickmanShannon DalessioWesley M Raup-KonsavageKent E VranaMatthew D CoatesPublished in: Inflammatory bowel diseases (2023)
Cannabis use in IBD patients is associated with several poor clinical outcomes, including increased risk of corticosteroid and opioid use, ED visits and hospitalization, though not IBD-related surgery or death. It is not clear what drives these risks or whether they are directly related to IBD-associated disease activity or other factors. Further prospective studies are warranted to more carefully investigate these relationships.
Keyphrases
- disease activity
- rheumatoid arthritis
- systemic lupus erythematosus
- end stage renal disease
- emergency department
- rheumatoid arthritis patients
- chronic kidney disease
- minimally invasive
- ankylosing spondylitis
- newly diagnosed
- ulcerative colitis
- prognostic factors
- juvenile idiopathic arthritis
- coronary artery bypass
- acute coronary syndrome
- coronary artery disease
- patient reported outcomes
- risk assessment
- patient reported
- atrial fibrillation
- percutaneous coronary intervention